39 related articles for article (PubMed ID: 6105802)
21. Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics.
Delini-Stula A
Pharmacopsychiatry; 1986 Jul; 19(4):134-9. PubMed ID: 2876445
[No Abstract] [Full Text] [Related]
22. [Dopamine antagonists and their mechanism of action].
Yamada K; Furukawa T
Nihon Rinsho; 1984 Apr; 42(4):808-14. PubMed ID: 6148436
[No Abstract] [Full Text] [Related]
23. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
Jenner P; Marsden CD
Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
[No Abstract] [Full Text] [Related]
24. The hypotheses of different dopamine receptor mechanisms.
Costall B; Naylor RJ
Life Sci; 1981 Jan; 28(3):215-29. PubMed ID: 6111725
[No Abstract] [Full Text] [Related]
25. Receptor plasticity: biochemical correlates and pharmacological significance.
Costa E
Adv Biochem Psychopharmacol; 1980; 24():363-77. PubMed ID: 6105787
[No Abstract] [Full Text] [Related]
26. The substituted benzamides--a novel class of dopamine antagonists.
Jenner P; Marsden CD
Life Sci; 1979 Aug; 25(6):479-85. PubMed ID: 40086
[No Abstract] [Full Text] [Related]
27. Characteristics of the vascular dopamine receptor: comparison with other receptors.
Goldberg LI; Kohli JD; Kotake AN; Volkman PH
Fed Proc; 1978 Aug; 37(10):2396-402. PubMed ID: 354973
[No Abstract] [Full Text] [Related]
28. Anti-schizophrenic drugs--membrane receptor sites of action.
Seeman P
Biochem Pharmacol; 1977 Oct; 26(19):1741-8. PubMed ID: 20896
[No Abstract] [Full Text] [Related]
29. Galactogogues: medications that induce lactation.
Gabay MP
J Hum Lact; 2002 Aug; 18(3):274-9. PubMed ID: 12192964
[TBL] [Abstract][Full Text] [Related]
30. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
Annunziato L; Quattrone A; Schettini G; Di Renzo G
Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
[No Abstract] [Full Text] [Related]
31. Functional dopamine receptors in the brain.
Woodruff GN; Holden-Dye L; Senior K; Poat JA
Neuropharmacology; 1984 Feb; 23(2B):243-6. PubMed ID: 6369165
[No Abstract] [Full Text] [Related]
32. New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations.
Högberg T; Rämsby S; Ogren SO; Norinder U
Acta Pharm Suec; 1987; 24(6):289-328. PubMed ID: 2898864
[No Abstract] [Full Text] [Related]
33. Chronopharmacological studies of neuroleptics.
Nagayama H; Takagi A; Takahashi R
Curr Dev Psychopharmacol; 1981; 6():191-214. PubMed ID: 6112118
[TBL] [Abstract][Full Text] [Related]
34. Dopamine receptor diversity: molecular and pharmacological perspectives.
Hartman DS; Civelli O
Prog Drug Res; 1997; 48():173-94. PubMed ID: 9204687
[No Abstract] [Full Text] [Related]
35. Drug effects on pre- and postsynaptic dopamine receptors.
Andén NE; Grabowska-Andén M
Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
[No Abstract] [Full Text] [Related]
36. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
Costentin J
Encephale; 1979; 5(2):121-49. PubMed ID: 38958
[TBL] [Abstract][Full Text] [Related]
37. Brain dopamine metabolism and behavioral problems of farm animals.
Sharman DF
Adv Biochem Psychopharmacol; 1978; 19():249-54. PubMed ID: 29448
[No Abstract] [Full Text] [Related]
38. The benzamides: evidence for action at dopamine receptors--shortcomings of current models.
Wazer DE; Rotrosen J; Stanley M
Adv Biochem Psychopharmacol; 1982; 35():83-95. PubMed ID: 6756063
[No Abstract] [Full Text] [Related]
39. Neuroleptic/dopamine receptors: elevation and reversal.
List S; Seeman P
Adv Biochem Psychopharmacol; 1980; 24():95-101. PubMed ID: 6105811
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
